Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
Merck Sharp & Dohme LLC
Toni K Choueiri; Piotr Tomczak; Se Hoon Park; Balaji Venugopal; Tom Ferguson; Stefan N Symeonides; Jaroslav Hajek; Yen-Hwa Chang; Jae-Lyun Lee; Naveed Sarwar; Naomi B Haas; Howard Gurney; Piotr Sawrycki; Mauricio Mahave; Marine Gross-Goupil; Tian Zhang; John M Burke; Gurjyot Doshi; Bohuslav Melichar; Evgeniy Kopyltsov; Ajjai Alva; Stephane Oudard; Delphine Topart; Hans Hammers; Hiroshi Kitamura; David F McDermott; Adriano Silva; Eric Winquist; Jerry Cornell; Aymen Elfiky; Joseph E Burgents; Rodolfo F Perini; Thomas Powles; KEYNOTE-564 Investigators